Manufacturer record
KRAS Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by KRAS Pharmaceuticals Pvt. Ltd (Bihar) were declared Not of Standard Quality between February 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to KRAS Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Gastro-resistant Tablets I.P. 50 mg | 25T19052Mfg 2025-02 · Exp 2027-01 | The sample does not conform to IP with respect to test for Dissolution in Buffer Stage.Dissolution | CDL, KolkataCDSCO lab | Dec 2025 |
| OMZOLE (Omeprazole Gastro Resistant Capsules IP) | 22C06001Mfg 2022-05 · Exp 2024-04 | Dissolution in Acid stageDissolution | RDTL GuwahatiState lab | Oct 2022 |
| Paracetamol Tablets I.P. 500 mg | 19T20003Mfg 2019-07 · Exp 2022-06 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.